Biomarker Discovery Outsourcing Services Market Size is valued at USD 12.16 billion in 2023 and is predicted to reach USD 52.82 billion by the year 2031 at a 20.38% CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
The demand for personalized therapies and companion diagnostics, which rely on biomarkers, stands as a fundamental driver in the biomarker discovery services market. Collaborative initiatives involving academic institutions, research organizations, and pharmaceutical companies in biomarker discovery projects stimulate growth by combining resources and expertise. The COVID-19 pandemic underscored the crucial significance of biomarkers in the realm of infectious disease diagnostics and public health. This heightened awareness, along with increased research funding, has ignited growth within the biomarker discovery services market. The existence of supportive regulatory frameworks and guidelines for biomarker development and validation plays a pivotal role in encouraging the utilization of biomarkers in clinical applications, further propelling market growth. Additionally, the urgency of the pandemic has specifically fueled augmented funding and research interest in biomarkers for infectious diseases, delivering a substantial boost to the market. The strict regulatory demands and compliance considerations may pose obstacles to the delegation of biomarker discovery services.
Moreover, organizations must verify that their selected service providers adhere to essential quality and safety criteria, a task that can be intricate and time-intensive. Biomarker discovery involves a multifaceted and intricate process. Uncovering biomarkers that are both meaningful and practical frequently necessitates a profound comprehension of biology, bioinformatics, and data analysis, a challenge that may take more work to achieve through outsourcing
The biomarker discovery outsourcing services market is segmented on the basis of type, therapeutic area, discovery phase and end users. Based on type, the market is segmented as predictive biomarkers, prognostic biomarkers, safety biomarkers and surrogate endpoints. By therapeutic area, the market is segmented as oncology, neurology, cardiology, autoimmune diseases and others. By the discovery phase, the market is segmented into biomarker identification, biomarker validation, biomarker profiling, biomarker panel development and biomarker selection. By end users, the market is segmented into pharmaceutical companies, biotechnology companies and others.
The biomarker validation category is expected to hold a major share of the global biomarker discovery outsourcing services market in 2024. The process of "biomarker validation" serves to confirm the accuracy, reliability, and clinical suitability of potential biomarkers. It encompasses both the discovery of biomarkers in research settings and their subsequent integration into clinical applications. The demand for biomarker validation services is substantial, primarily driven by the emphasis on translating research findings into clinical practice. Additionally, regulatory entities like the FDA and the European Medicines Agency (EMA) mandate rigorous validation of biomarkers to ensure their suitability for diagnostic, prognostic, or treatment selection purposes. These factors are anticipated to act as catalysts for market expansion.
The predictive biomarkers segment is projected to grow at a rapid rate in the global biomarker discovery outsourcing services market. Pharmaceutical and biotechnology firms are increasingly utilizing predictive biomarkers to identify patient groups with a higher likelihood of responding positively to experimental drugs. Predictive biomarkers are appealing from a commercial standpoint due to their capacity to expedite drug development and streamline regulatory approval processes, thereby leading to cost savings and revenue generation. Predictive biomarkers are instrumental in driving innovation and growth within the biomarker discovery outsourcing services market. They offer the promise of more effective treatments, reduced healthcare costs, and improved patient outcomes, making them a focal point in the field of biomarker research and development.
The North American biomarker discovery outsourcing services market is expected to register the highest market share. A strong focus on research and development, advanced healthcare infrastructure, regulatory support, collaborative partnerships, and significant funding characterizes the biomarker discovery outsourcing services market in North America. It plays a pivotal role in advancing personalized medicine and the development of innovative therapies. In addition, Asia Pacific is projected to grow at a rapid rate in the global biomarker discovery outsourcing services market. The Asia Pacific region has a diverse healthcare landscape with varying disease patterns and genetic profiles. This diversity creates opportunities for biomarker discovery, as specific biomarkers may be needed for different populations. Some countries in the region have initiated government-funded programs to support biomarker research and development. These programs aim to foster innovation and enhance the competitiveness of the biomarker discovery market in the Asia Pacific.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 12.16 Bn |
|
Revenue Forecast In 2031 |
USD 52.82 Bn |
|
Growth Rate CAGR |
CAGR of 20.38 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn, and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Component, Material, Capacity, Voltage, And Application |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; Southeast Asia |
|
Competitive Landscape |
Laboratory Corporation of America Holdings; Charles River Laboratories; Eurofins Scientific; Celerion; ICON plc.; Parexel International (MA) Corporation; Proteome Sciences; GHO Capital; Thermo Fisher Scientific Inc., Evotec., Bio-Rad Laboratories, Inc., Svar Life Science, Sino Biological, Inc, Almac Group Limited, REPROCELL Inc., Frontage Labs, Biomcare ApS, Crown Bioscience, RayBiotech, Inc., Other Market Players |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biomarker Discovery Outsourcing Services Market Snapshot
Chapter 4. Global Biomarker Discovery Outsourcing Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By Type:
5.2.1. Predictive biomarkers
5.2.2. Prognostic biomarkers
5.2.3. Safety biomarkers
5.2.4. Surrogate endpoints
Chapter 6. Market Segmentation 2: By Therapeutic Area Estimates & Trend Analysis
6.1. By Therapeutic Area & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By Therapeutic Area:
6.2.1. Oncology
6.2.2. Neurology
6.2.3. Cardiology
6.2.4. Autoimmune Diseases
6.2.5. Others
Chapter 7. Market Segmentation 3: By Discovery Phase Estimates & Trend Analysis
7.1. By Discovery Phase & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By Discovery Phase:
7.2.1. Biomarker Identification
7.2.2. Biomarker Validation
7.2.3. Biomarker Profiling
7.2.4. Biomarker Panel Development
7.2.5. Biomarker Selection
Chapter 8. Market Segmentation 4: By End-use Estimates & Trend Analysis
8.1. By End-use & Market Share, 2019 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By End-use:
8.2.1. Pharmaceutical Companies
8.2.2. Biotechnology Companies
8.2.3. Others
Chapter 9. Biomarker Discovery Outsourcing Services Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) estimates and forecasts By Type, 2024-2031
9.1.2. North America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2024-2031
9.1.3. North America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) estimates and forecasts By Discovery Phase, 2024-2031
9.1.4. North America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) estimates and forecasts By End-use, 2024-2031
9.1.5. North America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Type, 2024-2031
9.2.2. Europe Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Therapeutic Area, 2024-2031
9.2.3. Europe Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Discovery Phase, 2024-2031
9.2.4. Europe Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By End-use, 2024-2031
9.2.5. Europe Biomarker Discovery Outsourcing Services Market revenue (US$ Million) by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Type, 2024-2031
9.3.2. Asia Pacific Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Therapeutic Area, 2024-2031
9.3.3. Asia Pacific Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Discovery Phase, 2024-2031
9.3.4. Asia Pacific Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By End-use, 2024-2031
9.3.5. Asia Pacific Biomarker Discovery Outsourcing Services Market revenue (US$ Million) by country, 2024-2031
9.4. Latin America
9.4.1. Latin America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Type, (US$ Million) 2024-2031
9.4.2. Latin America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Therapeutic Area, (US$ Million) 2024-2031
9.4.3. Latin America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Discovery Phase, (US$ Million) 2024-2031
9.4.4. Latin America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By End-use, (US$ Million) 2024-2031
9.4.5. Latin America Biomarker Discovery Outsourcing Services Market revenue (US$ Million) by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Type, (US$ Million) 2024-2031
9.5.2. Middle East & Africa Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Therapeutic Area, (US$ Million) 2024-2031
9.5.3. Middle East & Africa Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By Discovery Phase, (US$ Million) 2024-2031
9.5.4. Middle East & Africa Biomarker Discovery Outsourcing Services Market revenue (US$ Million) By End-use, (US$ Million) 2024-2031
9.5.5. Middle East & Africa Biomarker Discovery Outsourcing Services Market revenue (US$ Million) by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1 Laboratory Corporation of America Holdings
10.2.2 Charles River Laboratories
10.2.3 Eurofins Scientific
10.2.4 Celerion
10.2.5 ICON plc.
10.2.6 Parexel International (MA) Corporation
10.2.7 Proteome Sciences
10.2.8 GHO Capital
10.2.9 Thermo Fisher Scientific Inc.
10.2.10 Evotec.
10.2.11 Bio-Rad Laboratories, Inc.
10.2.12 Svar Life Science
10.2.13 Sino Biological, Inc
10.2.14 Almac Group Limited
10.2.15 REPROCELL Inc.
10.2.16 Frontage Labs
10.2.17 Biomcare ApS
10.2.18 Crown Bioscience
10.2.19 RayBiotech, Inc.
10.2.20 Other Market Players
Biomarker Discovery Outsourcing Services Market By Type
Biomarker Discovery Outsourcing Services Market By Therapeutic Area
Biomarker Discovery Outsourcing Services Market By Discovery Phase
Biomarker Discovery Outsourcing Services Market By End-use
Biomarker Discovery Outsourcing Services Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
